Focus Stocks
Sanofi-Aventis Is in a Very Tight Range
Published on Thursday, 07 March 2013 08:48 Written by TradersHuddle Wire
New York, March 7th (TradersHuddle.com) - Shares of Sanofi-Aventis (NYSE:SNY) closed the trading session at $48.29 with its price action in a very tight range, given that calculated support is set at $46.16 and the calculated resistance is set at $48.75.
Sanofi-Aventis (NYSE:SNY) is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
Sanofi-Aventis' stock price action indicates that both sellers and buyers are materializing very close to each other. This signals an area where momentum is building, since the stock can resolve by breaking out of the developing tight range.
Traders wanting to establish a position should pay close attention to Sanofi-Aventis' price action, as any movement outside its predefined range of $46.16 and $48.75 could grasp the attention of momentum buyers that look for a big movement in the price of the stock. Traders need to be aware that tight range resolution works both ways, hence, a move below support could spark above the average selling. A tiered approach could be the best way to start a position; enter into it while the stock is in the tight range, and then add to this position as it breaks and closes above resistance.
Related Articles
- Critical Alerts For Sanofi, Salesforce.com, AFLAC, HCA Holdings, and Silver Wheaton Released By InvestorsObserver
- Sanofi-Aventis Is Close to the 50 Day Moving Average
- Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
- Approaching Resistance: Sanofi-Aventis
- Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
- Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month
- Reference Points for Sanofi-Aventis
- Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
- Approaching Resistance: Sanofi-Aventis
- Sanofi-Aventis Is Close to Resistance
Related Partner Headlines
- Sanofi Stock Buy Recommendation Reiterated (SNY) - TheStreet.com
- Sanofi (SNY): Today's Featured Drugs Laggard - TheStreet.com
- Zalicus Prednisporin Licensee Sanofi Provides Update on Development Status - Benzinga
- Sanofi Stock Buy Recommendation Reiterated (SNY) - TheStreet.com
- Sanofi Reaches New 52-Week High (SNY) - TheStreet.com
- Sanofi Stock Buy Recommendation Reiterated (SNY) - TheStreet.com
- Sanofi To Buy Genfar - Benzinga
- Sanofi Stock Buy Recommendation Reiterated (SNY) - TheStreet.com
- Sanofi (SNY): Today's Featured Health Care Laggard - TheStreet.com
- Sanofi Reaches New 52-Week High (SNY) - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,307.17 Trade time:4:44PM EDT Value change:▼80.41 (-0.52%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,655.35 Trade time:4:43PM EDT Value change:▼13.81 (-0.83%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,463.30 Trade time:5:15PM EDT Value change:▼38.82 (-1.11%)In The Wires
-
Canyon announces final annual meeting Board of Directors election results -
iSoftStone to Support 2013 MIT Sloan CIO Symposium -
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Websense, Inc. - WBSN -
Ghana Gold Corp. to Announce Material Information on Thursday, May 23 at 8am -
Lifshitz Law Firm Announces Investigation of BMC Software, Amyris, Inc., Market Leader, Inc., and True Religion Apparel, Inc. -
Lifshitz Law Firm Announces Investigation of BBX Capital Corporation, Crestwood Midstream Partners LP, Crimson Exploration Inc., and Pioneer Southwest Energy Partners L.P. -
Lifshitz Law Firm Announces Investigation of Chemed Corporation, Overhill Farms, Inc., Theragenics Corporation, and Websense, Inc. -
Lifshitz Law Firm Announces Investigation of AsiaInfo-Linkage, Inc., Commerce National Bank, CFS Bancorp, Inc., and IEC Electronics Corp.








